Showing results (221-230 of 1,367) with videos related to
Sort By:
Pageof 137
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2007
Patent foramen ovale closure: a new therapy for migraineMarkus Schwerzmann, Krassen Nedeltchev, Bernhard MeierBMC Infectious Diseases|February 8, 2023
A mouth watering case of Mycoplasma salivarium native mitral valve endocarditis: 'case report'Marc Scheen, Adrian Attinger, Tibor Huwyler, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stentsCrochan J O'Sullivan, Giulio G Stefanini, Lorenz Räber, et al.JACC. Cardiovascular Interventions|February 25, 2012
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromesBindu Kalesan, Giulio G Stefanini, Lorenz Räber, et al.Plos One|December 10, 2014
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary interventionThomas Pilgrim, Martina Rothenbühler, Bindu Kalesan, et al.American Heart Journal|June 7, 2011
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routesPeter Wenaweser, Thomas Pilgrim, Nadja Roth, et al.European Heart Journal. Quality of Care & Clinical Outcomes|December 20, 2021
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledgeLudovic Allard, Benedikt Bernhard, Stephan Windecker, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2018
Current state of alternative access for transcatheter aortic valve implantationJonas Lanz, Adam Greenbaum, Thomas Pilgrim, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2019
Evolving paradigms in valvular heart disease: where should guidelines move?Andreas Baumbach, Dariusz Dudek, Helmut Baumgartner, et al.Journal of the American College of Cardiology|November 1, 2005
Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery diseaseStephan Zbinden, Rainer Zbinden, Pascal Meier, et al.Pageof 137